The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
In the latest interview Ali's timeline for potential significant events was weeks rather than months.
Just saying.
That interview on Proactive is worth watching.
Something is going on. There were a string of buys several days ago; also kind of suddenly.
Something is stirring, not just my martini.
Something going on?
Now there's a buy of confidence..
🤣
Hope you didn’t wait for 5p
Fingers crossed for some news soon - a good and welcome rise today!
nice to see I'm not the only one with more silver threads amongst the coal as wait for for this sp to rocket.
As ever, a very competent display and good Proactive questions hitting a knowledgeable target. He's really energised by the AI input and emphasizes eTX's unique brand position.
I'm hoping for fireworks this year but can afford to sit on things. Sometimes I get the impression that our 'in since 2p' shares are wanted by some big fish in the background.
Solid enough RNS, requires patience waiting for collaborations and commercial agreements. No particular concerns here
Comms could be improved but this is pharma and timelines are long. Let’s see what the results reveal next week. They’re still advertising roles to grow the team which indicates confidence. I remain confidence. Recent SP drops are just the usual AIM malaise and lack of news. The SP has dropped a lot on very few sells
I’m not saying I have a better idea than anyone but Just because the ceo pumps millions of his own money into a company doesn’t guarantee he’s right (take a look at Chelsea fc for instance)..
I’m looking at the facts, this company tells shareholders absolutely nothing and the only rns’s we seem to read are placings or warnings of impending huge losses, sorry I’ve annoyed you in any way (not my intention) but that’s just the way it is.
So you seem to have a better idea than ceo who's spent a few mil of his own money on purchasing shares, and a few others come to think of it.
With your vast experience on RNAi and obviously GaINAc-siRNA to go with your exhaustive research posts on this site, I shall sell now and buy back at 5p.
5p incoming
Carlos64, how long have you been a holder?
10p incoming, and then after results 5p possibly 3p hopefully 5p is the bottom but with this company who knows they just don’t tell us anything
I think that merits an exclamation mark.
And we all thought they were playing chess but no...
'intense rate of innovation associated with developing a computationally driven in-house pipeline of RNAi drug candidates across a range of therapeutic areas. The new patent applications build on an active period of IP generation reported in 2022 where a series of patent applications were filed to protect 13 inventions. '
Good effort, Guys!
What’s your agenda/position here Carlos64? Sounds like you’ve had your fingers burned.
Only thing to go at here is another year of massive loss making with total silence from the inept board
What do you mean by plenty to go at?
Should be along soon, not heard anything for 4 months. Plenty to go at.
Seems a good re-entry point.
Gla
It’s definitely drifted downwards but I’m considering topping up. A director has recently added (albeit a small amount) and they’ve announced a recruitment drive so I don’t have any major concerns here. It’s always a slow burn with pharma
https://www.bbc.co.uk/news/health-64176038
More detail